acute [tmco]
effects [qlco]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
haemostatic [ortf]
variables [qlco]
Hour [tmco]
treatment [ftcn]
Study [mnob]
investigate [ftcn]
acute [tmco]
effects [qlco]
Transdermal [ftcn]
17beta estradiol [horm, phsu, strd]
Estraderm [horm, phsu, strd]
R- [spco]
Plasma [bdsu]
fibrinolytic [topp]
postmenopausal [tmco]
Normotensive [fndg]
hypertensive [fndg]
Women [popg]
Eleven [qnco]
Normotensive [fndg]
hypertensive [fndg]
Women [popg]
included [ftcn]
placebo controlled study [inpr, resa]
cross over [genf]
randomized [resa]
Order [inpr]
Subject [grup]
treated [topp]
Patch [fndg]
17beta estradiol [horm, phsu, strd]
placebo [topp]
24 hours [tmco]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
activity [dora]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
activity [dora]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Antigen [imft]
Pai [idcn]
I-antigen [aapp, imft]
FX [idcn]
Fibrinogen [aapp, bacs, phsu]
Assay [lbpr]
Treatments [topp]
haemostatic [ortf]
variables [qlco]
treatment [ftcn]
Estrogen [horm, phsu, strd]
Compared [acty]
Levels [qlco]
placebo [topp]
treatment [ftcn]
Group [idcn]
Measurable [ftcn]
hypertensive [fndg]
Normotensive [fndg]
Subject [grup]
